{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:30:46Z","timestamp":1782775846984,"version":"3.54.5"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T00:00:00Z","timestamp":1182988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Microbiology and Immunology"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:p><jats:bold>Introduction:\u2002<\/jats:bold> The aim of this study was to determine the current antimicrobial susceptibility of the principle anaerobic pathogens involved in dentoalveolar infection, to 13 oral antibiotics, and to assess the value of each antibiotic in the management of the infection.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A total of 800 isolates from patients with dentoalveolar infection (<jats:italic>Prevotella<\/jats:italic> species, <jats:italic>Fusobacterium<\/jats:italic> species, <jats:italic>Porphyromonas<\/jats:italic> species and <jats:italic>Peptostreptococcus micros<\/jats:italic>) were tested for their susceptibility to amoxicillin, amoxicillin\/clavulanate, cefaclor, cefuroxime, cefcapene, cefdinir, erythromycin, azithromycin, telithromycin, minocycline, levofloxacin, clindamycin, and metronidazole using an agar dilution method.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Although the majority of <jats:italic>Fusobacterium<\/jats:italic> strains were resistant to erythromycin, azithromycin, and telithromycin, the remaining antibiotics demonstrated a high level of antimicrobial activity. <jats:italic>P. micros<\/jats:italic> and <jats:italic>Porphyromonas<\/jats:italic> species exhibited high susceptibility to all antibiotics tested in this study. In the case of <jats:italic>Prevotella<\/jats:italic> species, resistance to amoxicillin occurred in 34% of isolates and all of these resistant strains were found to produce \u03b2\u2010lactamase. Susceptibility of <jats:italic>Prevotella<\/jats:italic> strains to cefaclor, cefuroxime, cefcapene, cefdinir, erythromycin, azithromycin, and minocycline was found to correlate with amoxicillin susceptibility. Amoxicillin\/clavulanate, telithromycin, clindamycin, and metronidazole exhibited high antimicrobial activity even against amoxicillin\u2010resistant strains of <jats:italic>Prevotella<\/jats:italic> species.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Amoxicillin would still be advocated therefore as being a suitable first\u2010line agent, while reduced susceptibility of <jats:italic>Prevotella<\/jats:italic> strains remains a matter of concern with penicillins. Amoxicillin\/clavulanate, clindamycin, and metronidazole are useful alternatives in combating the anaerobic bacteria involved in dentoalveolar infection.<\/jats:p>","DOI":"10.1111\/j.1399-302x.2007.00365.x","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T10:44:00Z","timestamp":1183027440000},"page":"285-288","source":"Crossref","is-referenced-by-count":108,"title":["Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics"],"prefix":"10.1111","volume":"22","author":[{"given":"T.","family":"Kuriyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Iwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,28]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1991.tb00464.x"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0757.2002.280109.x"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2001.00049.x"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0902-0055.2001.00096.x"},{"key":"e_1_2_3_6_2","first-page":"101","article-title":"Treatment of orofacial infections of odontogenic origin","volume":"46","author":"Heimdahl A","year":"1985","journal-title":"Scand J Infect Dis Suppl"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(80)90102-8"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.1.172-176.2006"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4812415"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2000.109639"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-302x.2001.160102.x"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0902-0055.2001.00098.x"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1996.tb00182.x"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-302X.2002.170501.x"},{"key":"e_1_2_3_15_2","first-page":"1073","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"Mandell GL","year":"1996"},{"key":"e_1_2_3_16_2","first-page":"672","volume-title":"Manual of clinical microbiology","author":"Murray PR","year":"1999"},{"key":"e_1_2_3_17_2","volume-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard","author":"National Committee for Clinical Laboratory Standards","year":"2004"},{"key":"e_1_2_3_18_2","first-page":"392","volume-title":"Contemporary oral and maxillofacial surgery","author":"Peterson LJ","year":"1998"},{"key":"e_1_2_3_19_2","first-page":"508","article-title":"Antimicrobial treatment options in the management of odontogenic infections","volume":"64","author":"Sandor GK","year":"1998","journal-title":"J Can Dent Assoc"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2005.00782.x"}],"container-title":["Oral Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-302X.2007.00365.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-302X.2007.00365.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T07:43:18Z","timestamp":1696923798000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-302X.2007.00365.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,28]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1399-302X.2007.00365.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-302x.2007.00365.x","archive":["Portico"],"relation":{},"ISSN":["0902-0055","1399-302X"],"issn-type":[{"value":"0902-0055","type":"print"},{"value":"1399-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,28]]}}}